The originating document has been archived. We cannot confirm the completeness, accuracy, or currency of the content.
PUREVAX Feline 3/Rabies
This page contains information on PUREVAX Feline 3/Rabies for veterinary use.The information provided typically includes the following:
- PUREVAX Feline 3/Rabies Indications
- Warnings and cautions for PUREVAX Feline 3/Rabies
- Direction and dosage information for PUREVAX Feline 3/Rabies
PUREVAX Feline 3/Rabies
This treatment applies to the following species:Feline Rhinotracheitis-Calici-Panleukopenia-Rabies Vaccine
Modified Live Virus, Canarypox Vector
RCP/rRabies
SWD
DESCRIPTION: PUREVAX® Feline 3/Rabies contains a nonadjuvanted lyophilized suspension of modified live feline rhinotracheitis, calici, and panleukopenia viruses; recombinant vectored rabies vaccine; plus a sterile water diluent. A canarypox vector has been modified, using recombinant technology, to produce expression of desired antigens capable of stimulating a protective immune response to rabies. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge tests in susceptible cats.
INDICATIONS: PUREVAX® Feline 3/Rabies is recommended for the vaccination of healthy cats 8 weeks of age and older for prevention of disease due to feline rhinotracheitis, calici, panleukopenia, and rabies viruses.
DOSAGE: Reconstitute the lyophilized vaccine with accompanying liquid diluent and aseptically inject 1 mL (1 dose) subcutaneously into healthy cats. For primary vaccination of cats younger than 12 weeks of age, revaccinate every 3 to 4 weeks with the last dose given at or over 12 weeks of age. For primary vaccination of cats 12 weeks or older, revaccinate with a second 1 ml dose of this product or Code 16D8.21 (Purevax® Feline 3), 3 to 4 weeks later. Revaccinate annually with a single 1 mL dose.
PRECAUTIONS: Store at 2-7°C (35-45°F). Use immediately after reconstitution. Do not use chemicals to sterilize syringes and needles. Burn this container and all unused contents. Contains gentamicin as a preservative. Do not vaccinate pregnant cats. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine.
SOLD TO VETERINARIANS ONLY.
For Veterinary Use Only.
PUREVAX is a registered trademark of MERIAL.
Manufactured By MERIAL INC., Athens, GA 30601 USA
U.S. Vet. Lic. No. 298
1-888-Merial-1 (1-888-637-4251)
Distributed In Canada By MERIAL CANADA, INC., Baie d’Urfé, (Québec), H9X 3V1, Canada
Contains |
|
Prod. No. |
|
25 Doses |
25 x 1 Dose, Lyophilized 25 x 1 mL, Sterile Water |
2132-25 |
RM820R6 |
CPN: 11110524
3239 SATELLITE BLVD., DULUTH, GA, 30096
Telephone: | 800-325-9167 | |
Fax: | 816-236-2717 | |
Website: | www.bi-vetmedica.com | |
www.metacam.com | ||
www.prrsresearch.com | ||
www.prozinc.us | ||
www.vetera-vaccines.com | ||
www.vetmedin-us.com | ||
Email: | info@productionvalues.us |
This service and data are provided "AS IS". DVMetrics and Drugs.com assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics and Drugs.com services and data. See the terms of use for further details. |
Copyright © 2024 Animalytix LLC. Updated: 2024-11-27